Search NLS News

The Swedish drug manufacturer APL (Apotek Produktion & Laboratorier) recently installed Vaisala’s viewLinc Continuous Monitoring system at its manufacturing plant, and has been delighted with the reliability and peace of mind that the system delivers. The quality of manufactured or processed products at cleanroom facilities are protected by applicable good manufacturing practices (GMP) that specify […]

Norwegian DNB Bank and US Back Bay Life Science Advisors have entered a partnership to combine scientific and strategic expertise with financing origination and execution capabilities. NLS asked Jonathan Gertler, Managing Partner & CEO of Back Bay Life Science Advisors, and Jan Upman, Senior Relationship Manager, DNB Bank, about the partnership and the opportunities this […]

Gedea Biotech has raised the financing to initiate and accelerate clinical trial activities supporting pHyph applicable for antibiotic free treatment of vaginal infections. The funds will be used to initiate patient recruitment in the recently approved registration CL3-2-study, reach upcoming data readout from the CL4 -study to obtain pHyph proof-of-concept for treating vaginal fungal infections, […]

The company has announced positive results from its Phase 1a clinical trial in healthy subjects. The clinical trial demonstrated favorable safety and tolerability, fast uptake of HER-096, and significant HER-096 concentrations in the cerebrospinal fluid (CSF) after a single subcutaneous injection, states the company in a press release. “We are very pleased with the topline […]

The company has raised SEK 54 million in a new share issue and has also been granted an additional SEK 29 million in innovation funding from the EU. The company has strengthened its financial position through a new share issue, with the investment company Sciety and investment syndicate Sciety Venture Partners. Alongside this, the company […]

FluoGuide has reported positive topline efficacy and safety results in the trial with the lead product FG001 for guiding surgery in aggressive brain cancer (high-grade glioma). “I am pleased with this first result of FG001 efficacy in aggressive brain cancer. Here is a promising drug and we should now define the best use of it […]

In the picturesque expanse of the Nordic region, a history of collaboration and shared values has woven a tapestry of unity that extends across borders and sectors. From the era of explorations to modern scientific frontiers, Nordic countries have fostered collaborative efforts to achieve scientific advancements, weathering challenges and celebrating successes. The roots of cross-border […]

For the past decade, Nordic Life Science Days (NLSDays) has been building business partnerships, highlighting innovations and showcasing all that the Nordic countries have to offer in the life science field. For its 10th anniversary, 29-30 November in Copenhagen, the planners expect to do that and more, including focusing on the latest developments in medicine […]

AstraZeneca and Eccogene have entered into an exclusive licence agreement for ECC5004, an investigational oral once-daily glucagon-like peptide 1 receptor agonist (GLP-1RA) for the treatment of obesity, type-2 diabetes and other cardiometabolic conditions. Preliminary results from the Phase I trial have shown a differentiating clinical profile for ECC5004, with good tolerability and encouraging glucose and body weight reduction across the […]

The company has announced plans to expand existing manufacturing facilities in Kalundborg, Denmark, for the current and future product portfolio within serious chronic diseases. The investment comes as Novo Nordisk marks the 100th anniversary of its founding in Denmark, where more than 23,000 employees still work today. Most of these employees work at production sites. […]